What is Agilent Technologies's remainder of fiscal year 2024?

Agilent Technologies (A) reported remainder of fiscal year 2024 of $37M in Q1 2026.

How has Agilent Technologies's remainder of fiscal year 2024 changed year-over-year?

Agilent Technologies's remainder of fiscal year 2024 decreased by 24.5% year-over-year, from $49M to $37M.

Agilent Technologies A Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

RevvityRVTY

——

Twist Bioscience CorporationTWST

——

Bio-Rad LaboratoriesBIO

——

AbbottABT

——

IlluminaILMN

——

Other financials

Income statement

See full

Revenue$1.8B+10.0%

Gross profit$990.0M+14.3%

Operating income$399.0M+33.0%

Net income$339.0M+57.7%

EPS (diluted)$1.20+60.0%

Balance sheet

See full

Cash & equivalents$1.8B+21.5%

Total debt$3.5B-3.9%

Total equity$7.1B+16.1%

Total assets$13.1B+7.5%

Cash flow

See full

Operating cash flow$277.0M+25.3%

CapEx$76.0M-33.3%

Free cash flow$201.0M+87.9%

Valuation

See full

Market cap$37.52B+8.8%

Enterprise value$39.25B+7.0%

P/E26.5×-3.0×

P/S5.2×0.0×

Profitability

See full

Gross margin52.7%-0.6pp

Operating margin21.5%+0.1pp

Net margin19.6%+2.0pp

FCF margin15%-2.9pp

Returns & leverage

See full

Return on equity21.3%+2.4pp

Debt / equity0.5×-0.1×

Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agilent Technologies's remainder of fiscal year 2024?: Agilent Technologies (A) reported remainder of fiscal year 2024 of $37M in Q1 2026.
How has Agilent Technologies's remainder of fiscal year 2024 changed year-over-year?: Agilent Technologies's remainder of fiscal year 2024 decreased by 24.5% year-over-year, from $49M to $37M.